Keyboard graph navigation: press N for concepts or E for relations; use arrow keys, Home, and End to move; Enter selects; Shift plus Enter selects and centers; plus and minus zoom; zero fits; Escape clears the selection. Use the visible viewport buttons as alternatives to dragging, wheel, and pinch gestures.
Canonical static concept record
Open this concept in the interactive graphRead the Markdown equivalent
A medicinal preparation containing a radionuclide in a chemical form designed for diagnostic measurement or targeted therapy.
wp-chem-radiochemistryiaea-neutron-activation-analysisiupac-gold-bookEach relation below ends at this concept.
This is an authored directed relation from the source endpoint to the target endpoint.
Many radiopharmaceuticals use chelators to control radionuclide speciation, targeting, kinetic stability, and in vivo distribution.
The source is a material constituent, structural component, or underlying quantum field whose excitation realizes the target physical system or particle. The edge label and detail must distinguish composition from field excitation; neither implies a simple classical sum of parts.
wp-chem-inorganic-chemistryiupac-red-bookiupac-gold-bookThis is an authored directed relation from the source endpoint to the target endpoint.
A selected radionuclide is a material component of a radiopharmaceutical, joined to formulation and often a targeting vector; decay properties, dosimetry, purity, stability, and biology govern use.
The source is a material constituent, structural component, or underlying quantum field whose excitation realizes the target physical system or particle. The edge label and detail must distinguish composition from field excitation; neither implies a simple classical sum of parts.
wp-chem-radiochemistryiaea-neutron-activation-analysisiupac-gold-bookEach relation below starts at this concept.
No direct relations are authored in this direction.